Purple Biotech: Funding, Investors & Team (Sep 2026)
Kitov Pharmaceuticals is an innovative biopharmaceutical drug development company. Leveraging deep regulatory and clinical-trial expertise, Kitov's veteran team of healthcare professionals maintains a proven track record in streamlined end-to-end drug development and approval. The company was founded in 2010 and is headquartered in Tel Aviv, Israel.
Purple Biotech has raised $9.8M across 3 funding rounds on record, the most recent an undisclosed round of $2.8M announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Purple Biotech Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Purple Biotech Funding Rounds
Purple Biotech raised $5.0M in an undisclosed round announced in Oct 2023.
9 months later, an undisclosed round of $2.0M was announced in Jul 2024.
5 months later, an undisclosed round of $2.8M was announced in Dec 2024.
Purple Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Purple Biotech Funding Compared to Other Biotechnology Startups
Purple Biotech's latest round of $2.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Purple Biotech in Biotechnology and Tel Aviv
Companies Similar to Purple Biotech
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Purple Biotech Funding FAQs
What does Purple Biotech do?
Kitov Pharmaceuticals is an innovative biopharmaceutical drug development company. Leveraging deep regulatory and clinical-trial expertise, Kitov's veteran team of healthcare professionals maintains a proven track record in streamlined end-to-end drug development and approval. The company was founded in 2010 and is headquartered in Tel Aviv, Israel.
How much funding has Purple Biotech raised?
Purple Biotech has raised $9.8M across 3 rounds on record. The most recent is an undisclosed round of $2.8M announced in Dec 2024.
When did Purple Biotech last raise funding?
Purple Biotech's most recent funding round on record is an undisclosed round of $2.8M, announced in Dec 2024.
Who founded Purple Biotech?
FundedIQ lists John Paul Waymack (Founder) at Purple Biotech.
Where is Purple Biotech headquartered?
Purple Biotech is based in Tel Aviv, Israel.
How many employees does Purple Biotech have?
Purple Biotech is in the 11-50 employee band.
How does Purple Biotech's funding compare to other Biotechnology startups?
Purple Biotech's latest round of $2.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Purple Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Purple Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.